168 related articles for article (PubMed ID: 14679854)
1. [Systemic sclerosis: drugs and new therapeutic methods].
Skretkowicz K; Waszczykowska E; Dziankowska-Bartkowiak B
Pol Merkur Lekarski; 2003 Sep; 15(87):263-7. PubMed ID: 14679854
[TBL] [Abstract][Full Text] [Related]
2. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?].
Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D
Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
4. The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide.
Oliver SJ
Curr Rheumatol Rep; 2000 Dec; 2(6):486-91. PubMed ID: 11123102
[TBL] [Abstract][Full Text] [Related]
5. Effects of immunomodulating therapy in systemic sclerosis.
van den Hoogen FH; Boerbooms AM; van de Putte LB
Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
[TBL] [Abstract][Full Text] [Related]
6. Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis.
Gluszko P; Undas A; Kwasny B; Musiał J; Szczeklik A
Thromb Res; 1998 Aug; 91(4):203-7. PubMed ID: 9736424
[No Abstract] [Full Text] [Related]
7. Comorbidity influences therapeutic approach in multiple sclerosis.
Capone F; Ferraro E; Florio L; Marcoccia A; Di Lazzaro V; Di Battista G
Clin Neurol Neurosurg; 2017 Apr; 155():14-16. PubMed ID: 28212926
[No Abstract] [Full Text] [Related]
8. Treatment of systemic sclerosis.
Medsger TA
Curr Opin Rheumatol; 1990 Dec; 2(6):956-9. PubMed ID: 2128028
[No Abstract] [Full Text] [Related]
9. Relationships between serotoninergic system and skin fibrotic.
Huang J; Gong Q; Huang C; Li G
Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):9-16. PubMed ID: 23909604
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis.
Hughes M; Herrick A
Br J Hosp Med (Lond); 2012 Sep; 73(9):509-10, 511-6. PubMed ID: 23124403
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.
Young A; Khanna D
Curr Opin Rheumatol; 2015 May; 27(3):241-8. PubMed ID: 25775190
[TBL] [Abstract][Full Text] [Related]
12. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
Pałgan K; Pałgan I; Dziedziczko A
Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168
[TBL] [Abstract][Full Text] [Related]
13. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
Arnaudova P; Rashkov R; Tsanev R
J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
[No Abstract] [Full Text] [Related]
14. Treatment of systemic sclerosis.
Medsger TA
Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
[TBL] [Abstract][Full Text] [Related]
15. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
Sicińska J; Rudnicka L
Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
[TBL] [Abstract][Full Text] [Related]
16. Treatment of scleroderma.
Sapadin AN; Fleischmajer R
Arch Dermatol; 2002 Jan; 138(1):99-105. PubMed ID: 11790173
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide in systemic sclerosis: light and shadows.
Vlachoyiannopoulos PG; Ioannidis JP
Clin Exp Rheumatol; 2004; 22(5):551-2. PubMed ID: 15485005
[No Abstract] [Full Text] [Related]
18. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
Jain S; Shahane A; Derk CT
Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
[TBL] [Abstract][Full Text] [Related]
19. Long-term cyclosporin A in systemic sclerosis.
Roch B; Wollina U; Schroeder HE
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):235-6. PubMed ID: 15009322
[No Abstract] [Full Text] [Related]
20. [Systemic sclerosis].
Villiger PM
Ther Umsch; 2008 May; 65(5):283-7. PubMed ID: 18622933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
